Cargando…
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart
Arterial occlusive events (AOEs) represent emerging complications in chronic myeloid leukemia (CML) patients treated with ponatinib. We identified 85 consecutive CML adult patients who were treated with ponatinib in 17 Italian centers. Patients were stratified according to the Systematic Coronary Ri...
Autores principales: | Caocci, Giovanni, Mulas, Olga, Abruzzese, Elisabetta, Luciano, Luigiana, Iurlo, Alessandra, Attolico, Immacolata, Castagnetti, Fausto, Galimberti, Sara, Sgherza, Nicola, Bonifacio, Massimiliano, Annunziata, Mario, Gozzini, Antonella, Orlandi, Ester Maria, Stagno, Fabio, Binotto, Gianni, Pregno, Patrizia, Fozza, Claudio, Trawinska, Malgorzata Monika, De Gregorio, Fiorenza, Cattaneo, Daniele, Albano, Francesco, Gugliotta, Gabriele, Baratè, Claudia, Scaffidi, Luigi, Elena, Chiara, Pirillo, Francesca, Scalzulli, Emilia, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766852/ https://www.ncbi.nlm.nih.gov/pubmed/30892724 http://dx.doi.org/10.1002/hon.2606 |
Ejemplares similares
-
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
por: Caocci, Giovanni, et al.
Publicado: (2020) -
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
por: Breccia, Massimo, et al.
Publicado: (2020) -
Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
por: Annunziata, Mario, et al.
Publicado: (2020) -
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
por: Soverini, Simona, et al.
Publicado: (2019) -
Flow Cytometry Assessment of CD26(+) Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia
por: Raspadori, Donatella, et al.
Publicado: (2019)